Category hub
High activity category
This category has a significant number of recalls. Check it regularly if you own products in this area.
Cook Medical identified that products supplied in the affected device lots may have been manufactured out of specification. Impacted products may have been cut to the incorrect length, not correctly trimmed, and not inspected properly.
Taro Pharmaceuticals recalled Clindamycin Phosphate USP, 1% topical solution on November 26, 2025. The recall affects specific lots due to failed impurity testing. Consumers should stop using the product immediately and consult healthcare providers.
Cook Medical identified that products supplied in the affected device lots may have been manufactured out of specification. Impacted products may have been cut to the incorrect length, not correctly trimmed, and not inspected properly.
Ferndale Laboratories recalled 24,589 vials of Mastisol Liquid Adhesive due to a defect. The butyrate tube may crack during use, making the product unusable. The recall affects products distributed in the U.S. and the U.K., announced on November 25, 2025.
Draeger, Inc. recalled 188 units of the Vapor 3000 anesthetic vaporizer on November 24, 2025. The devices contained impurities in a component not delivered within specification. Healthcare providers and patients must stop using the devices immediately.
Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
A certain component of affected devices was not delivered within specification and contained impurities.
Towa Pharmaceuticals recalled 3,397 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations resulting in N-nitroso-duloxetine levels exceeding FDA limits. Consumers must stop using the product immediately.
Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Alcon Laboratories, Inc. recalled 151 units of Custom Pak surgical procedure packs on November 24, 2025. The recall stems from incomplete seals that may affect sterility. Healthcare providers and patients should stop using the products immediately.
Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Changchun Wancheng Bio-Electron Co. recalled 1,000 units of S. Typhi/Para Typhi A Antigen test strips on November 22, 2025. The recall affects tests distributed nationwide, which may produce false results and lead to inappropriate medical intervention.
Changchun Wancheng Bio-Electron Co. recalled 1,000 male fertility sperm tests on November 22, 2025. The tests were distributed without proper FDA clearance and may yield inaccurate results. This could lead to inappropriate medical interventions by users.